A detailed history of Acadian Asset Management LLC transactions in Biote Corp. stock. As of the latest transaction made, Acadian Asset Management LLC holds 93,250 shares of BTMD stock, worth $485,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,250
Previous 115,869 19.52%
Holding current value
$485,832
Previous $670,000 3.73%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$5.44 - $7.47 $123,047 - $168,963
-22,619 Reduced 19.52%
93,250 $695,000
Q1 2024

May 10, 2024

SELL
$3.79 - $6.91 $12,908 - $23,535
-3,406 Reduced 2.86%
115,869 $670,000
Q4 2023

Feb 13, 2024

SELL
$4.43 - $5.81 $89,884 - $117,884
-20,290 Reduced 14.54%
119,275 $589,000
Q3 2023

Nov 13, 2023

BUY
$4.73 - $7.83 $660,142 - $1.09 Million
139,565 New
139,565 $712,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $39.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.